Cambridge Innovation Institute completed the acquisition of Evaluating Biopharma.

Cambridge Innovation Institute, a company that delivers cutting edge information through events, publishing, and training, completed the acquisition of Evaluating Biopharma, a networking and education events provider. Financial terms were not disclosed. "We are regularly looking for additional ways to work with and provide valuation content to those in the bioprocessing field. Evaluating Biopharma provides an excellent means of expanding our range of offerings for this rapidly growing industry segment. Their rare blend of education and networking is an ideal match for our Cambridge Healthtech Institute event portfolio," Phillips Kuhl, Cambridge Innovation Institute President.